Endotrophin is a risk marker of complications in CANagliflozin cardioVascular Assessment Study (CANVAS): a randomized controlled trial

BACKGROUND: Enhanced de-novo collagen type VI (COL VI) formation has been associated with kidney and cardiovascular fibrosis. We hypothesized that endotrophin (ETP), a product specifically generated during collagen type VI formation, may be prognostic for heart failure (HF), cardiovascular death (CV...

Descripción completa

Detalles Bibliográficos
Autores principales: Rasmussen, Daniel Guldager Kring, Hansen, Michael K., Blair, Joseph, Jatkoe, Timothy A., Neal, Bruce, Karsdal, Morten A., Genovese, Federica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706889/
https://www.ncbi.nlm.nih.gov/pubmed/36443792
http://dx.doi.org/10.1186/s12933-022-01666-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706889/
https://www.ncbi.nlm.nih.gov/pubmed/36443792
http://dx.doi.org/10.1186/s12933-022-01666-7

Ejemplares similares